Page 40 - MEMOCiberer014-ENG

The primary activities for promoting the Transfer performed by CIBERER are the following:
DEVELOPMENT OF TOOLS FOR TRANSFER PROCESSES
First, CIBERER continues providing advisory services relating to intellectual property and other aspects relating to the transfer . This task was coordinated by Scientific Management with the support of the company Clarke, Modet & Co . Researchers channelled all their queries relating to the protection of R&D&I activities generated while carrying out their projects, and received guidance and support about applying good practices in management of the measures for protecting project results .
Furthermore, extensive work has been done in order to identify and valorise products and services potentially transferable to the different CIBERER groups .
CIBERER is a full member of ASEBIO (Asociación Española de Bioempresas) . In 2014, CIBERER continued its activity within the Innovate Drug group, the specific Rare Diseases and Advanced Therapies subgroups, as well as in the Molecular Diagnosis Work Group, actively participating in the different meetings . Since 2011, CIBERER has also been an associate member of BIOVAL (Bioregión de la Comunidad Valenciana) . Since 2013 it has been a collaborating partner in the Medical and Health Innovation Technologies (ITEMAS) Platform . The ITEMAS Platform seeks to encourage innovation in health technology as a fundamental tool to make the National Health System more sustainable, supporting the development of the innovative culture necessary to facilitate integrating the science-industry system in the field of medical technology .
PARTICIPATION IN FORUMS AND EVENTS ENABLING COLLABORATION WITH THE PRIVATE SECTOR
Finally, in 2014 the Management Office staff and the CIBERER Management attended and participated in other forums and events of particular interest enabling some type of collaboration with the private sector, such as:
• TRANSFIERE which took place on 13-14 February 2014 in Málaga . • BIOSPAIN 2014 held in Santiago de Compostela on 24-26 September 2014, numerous researchers
of the centre also participating .
• VI Spanish Drug Discovery Network Meeting which took place in the Science Park of Madrid at the head office of Glaxo Smith Kline, 20-21 November 2014
Furthermore, CIBERER has participated in several conference and workshops, organising them in collaboration with companies to deal with different aspects relating to the aetiology, causes, clinical symptoms and treatment of RDs:
• World Rare Disease Day, “Investigar es avanzar” in the Instituto de Investigación Príncipe Felipe de Valencia, . Several companies and institutions representing the private sector attended .
• DNA-Day CIBERER Workshop at Hospital Universitario La Paz de Madrid with the collaboration of Roche, Genycell Biotech, Sistemas Genómicos, Agilent Technologies, Abyntek, Progenika and Perkin Elmer .
• International symposium on nerve biology and inherited peripheral neuropathies organised in collaboration with the Fundación Ramón Areces on 11 and 12 December in Madrid .
40
CIBERER » Annual report 2014